BHASKAR CHAUDHURI
CIK 1458643 · President · last filed 2026-06-29
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$24.88M
Companies
6
Total Filings
59
Lifetime Open-Market Net
-$1.61M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TARS | Director | 11,654 | $69.46 | $809.5K | $0 | 9 | 2026-06-29 |
| ARQT | Director | 917,807 | $26.23 | $24.07M | -$2.11M | 16 | 2025-06-16 |
| Teligent, Inc. (TLGT) Delisted | Director | — | $0.17 | — | $0 | 1 | 2021-01-06 |
| Corium International, Inc. (CORI) Delisted | Director | — | — | — | $0 | 5 | 2018-11-28 |
| IG | Director | — | $20.20 | — | $0 | 2 | 2014-01-06 |
| VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted | President | 10,283 | — | — | $500.1K | 17 | 2010-10-20 |
Recent Filings · Page 6 of 6
59 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2009-06-11 | VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted | Grant (A) | +6,010 | $0 | EDGAR |
| 2009-05-26 | VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted | Buy (P) | +1,352 | $30.0K | EDGAR |
| 2009-05-18 | VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted | Buy (P) | +1,360 | $30.0K | EDGAR |
| 2009-05-13 | VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted | Grant (A) | +3,435 | $0 | EDGAR |
| 2009-05-12 | VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted | Buy (P) | +1,538 | $30.0K | EDGAR |
| 2009-05-04 | VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted | Buy (P) | +1,760 | $30.0K | EDGAR |
| 2009-04-27 | VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted | Buy (P) | +1,732 | $30.0K | EDGAR |
| 2009-04-21 | VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted | Buy (P) | +1,703 | $30.0K | EDGAR |
| 2009-03-20 | VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted | Grant (A) | +77,839 | $0 | EDGAR |
Showing 51–59 of 59
Prev
Page 6 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.